Location History:
- Yongin-si, KR (2016 - 2018)
- Seoul, KR (2019 - 2024)
Company Filing History:
Years Active: 2016-2025
Of course! Here is the article about the inventor Young Jun Koh:
Title: Young Jun Koh: Innovating Cancer Treatment with Fusion Proteins
Introduction:
Young Jun Koh is a prolific inventor hailing from Yongin-si, South Korea, with an impressive portfolio of 11 patents. His groundbreaking work in the field of pharmaceutical compositions for cancer treatment has garnered significant attention in the scientific community.
Latest Patents:
Young Jun Koh's latest patents showcase his innovative approach to cancer treatment. One of his patents involves a pharmaceutical composition comprising a fusion protein containing an IL-2 protein and a CD80 protein, along with an anticancer agent. This composition aims to enhance immune activity in the body, effectively inhibiting cancer growth and showing promise for the treatment of infectious diseases as well.
Another recent patent by Young Jun Koh focuses on a pharmaceutical composition for cancer treatment, combining an immune checkpoint inhibitor antibody with a fusion protein comprising an IL-2 mutant and a CD80 extracellular domain. This composition has demonstrated the ability to activate immune cells and control immune cell regulatory activity, leading to the effective inhibition of cancer when used in conjunction with an immune checkpoint inhibitor like Keytruda.
Career Highlights:
Young Jun Koh has made significant contributions to the field of cancer treatment during his tenure at companies like Samsung Electronics Co., Ltd. and Gi Innovation, Inc. His innovative research and patent portfolio underscore his dedication to advancing medical science and improving cancer therapies.
Collaborations:
Throughout his career, Young Jun Koh has collaborated with esteemed coworkers such as Kwang Ho Cheong and Seung Hyun Lee. These partnerships have been instrumental in developing groundbreaking pharmaceutical compositions for cancer treatment, showcasing the power of teamwork in driving innovation.
Conclusion:
Young Jun Koh's inventive spirit and commitment to revolutionizing cancer treatment have positioned him as a leading figure in the field of biomedical research. His patents reflect a deep understanding of immunotherapy and its potential to transform the way we approach cancer care. With a track record of success and a passion for innovation, Young Jun Koh continues to push the boundaries of medical science, offering hope to patients worldwide.